Searched for
INSULIN PRODUCTION USA
Pharma sector: Look beyond the tariff reprieve for generics. 6 mid-cap pharma stocks with an upside potential of more than 23%With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tar...29 Sep, 2025, 08.10 PM IST- Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...28 Jul, 2025, 06.54 PM IST
- Don’t fear volatility, focus on businesses: 5 mid-cap stocks from different sectors with upside potential of up to 27%For all those who thought that a bullish market doesn't see volatility, the way the street has behaved in the last few days is a reminder t...20 Jul, 2025, 12.26 PM IST
- Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...12 Jul, 2025, 11.25 AM IST
- Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulinWockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing new antibiotics...11 Jul, 2025, 05.15 PM IST
- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...28 Jun, 2025, 04.28 PM IST
- Ignore volatility and look for long-term opportunities: 5 mid-cap stocks from different sectors with upside potential of over 23%While the Nifty and Sensex are volatile, the number of stocks advancing and declining, indicative of market breadth, are pretty much even. ...03 Jun, 2025, 01.31 PM IST
- Time to take the first step toward a higher risk quotient? 6 mid-cap stocks with upside potential of more than 24%There is no escaping this fact: In a growing economy like India, you have to be bullish. Because the Nifty and Sensex have been correcting ...18 Feb, 2025, 01.28 PM IST
- Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI...28 Oct, 2024, 03.34 PM IST
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...03 Oct, 2024, 03.18 PM IST
- Best Selling Mini Refrigerators Under 15000 in India in 2024Looking for a compact cooling solution that offers a little bit of everything without putting a financial strain in your pockets? Well, loo...03 Apr, 2024, 10.05 PM IST
- Habil Khorakiwala on 3 things in the pipeline that can cause a re-rating for WockhardtHabil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to m...27 Dec, 2023, 01.08 PM IST
- Govt grants sanction to prosecute joint drugs controller S Eswara Reddy in Biocon Biologics bribery caseEswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics' Associate Vice President L Praveen Kumar, and Synergy ...23 Jul, 2023, 04.15 PM IST
- 7 midcap stocks, 1 with “Strong Buy” and 6 with “Buy” recommendations with potential upside of up to 30%Four pharma companies, a southern india focussed real estate player to mid-cap software company have seen an improvement in their overall s...27 Dec, 2022, 11.28 AM IST
- Biocon's oral insulin will take few more years to hit market: Kiran Mazumdar ShawBiocon my take a few more years to launch its oral insulin in the Indian market, said company's Chairman and Managing Director Kiran Mazumd...14 Sep, 2013, 09.29 PM IST
- Advinus Therapeutics finds $1-bn biz in new moleculeBuoyed by the success of discovering a novel molecule for the treatment of type II diabetes, pharma research start-up Advinus Therapeutics ...26 Nov, 2010, 03.10 AM IST
- Shreya group targeting over Rs 500-cr turnover this fiscalBio-pharma major, Russia-based Shreya group is targeting a turnover of more than Rs 500-crore this fiscal, a top company official said toda...13 Nov, 2008, 05.56 PM IST
Load More
